A randomized, double-blind, placebo-controlled trial was performed to assess the efficacy of once daily budesonide in patients with nasal polyps. After a a-week run-in period 157 patients with symptomatic bilateral nasal polyposis were randomized to receive budesonide, 140 mug once or twice daily or 280 mug once daily (delivered doses) via Turbuhaler(R), or placebo for 8 weeks. Polyp size was assessed endoscopically and, in two centres, by magnetic resonance imaging (MRI). Nasal symptoms (blocked nose, runny nose, sneezing) were recorded daily, and patients provided an overall assessment of efficacy at the end of the study. Budesonide, 280 mug/day (280 mug o.d. and 140 mug twice daily), significantly reduced polyp size, compared with placeb...
Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and ...
Objective: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in th...
Background: Patients with eosinophilic nasal polyposis frequently require surgery, and recurrence ra...
Objective: To evaluate the efficacy and safety of mometasone furoate nasal spray (NS) for the treatm...
PubMedID: 12927289Objective: The objectives of the management of nasal polyposis are to eliminate or...
Cell resistance to glucocorticoids is a major problem in the treatment of nasal polyposis (NP). The ...
Background: Topical and systemic corticosteroids are the first choice in medical treatments for sino...
Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and ...
Background : To compare the effectiveness of topical steroid and oral steroid in reducing size of po...
Background: There is little scientific evidence to support the current practice of using oral glucoc...
Nasal polyp is macroscopic edematous mass and it is a most common nasal complaint of the patients. T...
BackgroundThere is little evidence on the efficacy of glucocorticoid transnasal nebulization therapy...
Background: There is little evidence on the efficacy of glucocorticoid transnasal nebulization thera...
There is little scientific evidence to support the current practice of using oral glucocorticosteroi...
Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and ...
Objective: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in th...
Background: Patients with eosinophilic nasal polyposis frequently require surgery, and recurrence ra...
Objective: To evaluate the efficacy and safety of mometasone furoate nasal spray (NS) for the treatm...
PubMedID: 12927289Objective: The objectives of the management of nasal polyposis are to eliminate or...
Cell resistance to glucocorticoids is a major problem in the treatment of nasal polyposis (NP). The ...
Background: Topical and systemic corticosteroids are the first choice in medical treatments for sino...
Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and ...
Background : To compare the effectiveness of topical steroid and oral steroid in reducing size of po...
Background: There is little scientific evidence to support the current practice of using oral glucoc...
Nasal polyp is macroscopic edematous mass and it is a most common nasal complaint of the patients. T...
BackgroundThere is little evidence on the efficacy of glucocorticoid transnasal nebulization therapy...
Background: There is little evidence on the efficacy of glucocorticoid transnasal nebulization thera...
There is little scientific evidence to support the current practice of using oral glucocorticosteroi...
Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and ...
Objective: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in th...
Background: Patients with eosinophilic nasal polyposis frequently require surgery, and recurrence ra...